We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Seco Spa | BIT:IOT | Italy | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.056 | 3.59% | 1.616 | 1.56 | 1.648 | 1.626 | 1.566 | 1.57 | 198,257 | 17:00:00 |
RNS Number:7216U iSoft Group PLC 28 January 2004 28 January 2004: embargoed for release at 11am iSOFT Group plc ("iSOFT" or the "Company") Analyst briefing At 11.00 am today, iSOFT will be briefing analysts on the impact on the Company of the NHS National Procurement for Information Technology ("NPfIT") and on latest developments in the competition authorities' review of its merger with Torex PLC ("Torex"). The NPfIT iSOFT will confirm that it has been selected as principal applications provider in respect of the following regions: Region Local Service Provider Expected initial total contract value to iSOFT* East Accenture #89 million North East Accenture #79 million North West & Midlands CSC #132 million *In respect of software licence and maintenance fees only. The initial focus of the National Programme will be to commence a four year plan to install and run new systems. Competition review The review by the Office of Fair Trading ("OFT") of the merger of iSOFT with Torex is nearing completion. The OFT decision is anticipated following the outcome of the Court of Appeal hearing of the appeal from the Competition Appeal Tribunal, which is expected to commence on Tuesday 3 February. In the meantime, as this is a completed merger, iSOFT has given undertakings to the Office of Fair Trading, in accordance with section 71 of the Enterprise Act 2002 (the "Act"), that it will not, prior to the conclusion of the review by the UK competition authorities, take any action which might (a) lead to the integration of the Torex UK healthcare IT business with the business of iSOFT or (b) prejudice any reference to the Competition Commission or impede the taking of any action under the Act which may be justified by the Commission's decision in the event of a reference. These undertakings are without prejudice to the OFT's ultimate decision. Further information in this regard is expected to be published in due course on www.oft.gov.uk. Commenting on the announcement, Patrick Cryne, Chairman of iSOFT, noted: "This is a very exciting time for iSOFT. We are very pleased by the outcome of the NPfIT and by the completion of our merger with Torex, and look forward to realising the opportunities now open to us." Ends Enquiries: iSOFT Group plc: +44 (0) 161 935 8800 Patrick Cryne, Executive Chairman Tim Whiston, Group Finance Director Hoare Govett Limited: +44 (0) 20 7678 8000 Chris Fielding Andrew Chapman Financial Dynamics: +44 (0) 20 7831 3113 Giles Sanderson James Melville-Ross This information is provided by RNS The company news service from the London Stock Exchange END MSCUWVRRSURAUAR
1 Year Seco Chart |
1 Month Seco Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions